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Abstract Various catalytically active antibodies or abzymes 
have been detected recently in the sera of patients with several 
autoimmune pathologies, where their presence is most probably 
associated with autoimmunization. Normal humans are generally 
considered to have no abzymes, since no obvious immunizing 
factors are present. Recently we have shown that IgG (its Fab 
and F(ab)2 fragments) from the milk of normal humans possesses 
DNase activity. Here we demonstrate for the first time that the 
light chain of IgG catalyzes the reaction of DNA hydrolysis. 
These findings speak in favor of the generation of abzymes in the 
tissue of healthy mothers, and since a mother's breast milk 
protects her infant from infections until the immune system is 
developed, they raise the possibility that these abzymes may 
contribute to this protective role. 
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1. Introduction 
The field of catalytically active antibodies or abzymes has 
been amply reviewed recently [1-6]. Patients with autoimmune 
diseases produce antibodies (Abs) to nucleoprotein complex 
[7], to DNA and to enzymes that participate in nucleic acid 
metabolism [8]. In autoimmune diseases, there can be sponta-
neous induction of anti-idiotypic Abs, which are Abs elicited 
by a primary antigen, including catalytic activity. Peptide- [9], 
protein- [10], DNA- [11-13] and RNA-hydrolyzing auto-Abs 
[14-16] were detected in the sera of patients with several auto-
immune pathologies. Since no obvious immunizing factors are 
found in normal humans, they are considered to have no 
abzymes. 
Human milk provides the breast-fed child not only with 
nutrients but also with a mucosal immune system. Milk con-
tains Abs to bacterial, viral, and protozoal antigens [17-20], 
which reach mucosal surfaces in the respiratory and gastro-
intestinal tracts and as a result protect the infants from in-
fections and diseases. Passive immunity of the child may be 
acquired also from IgG in the mother's milk after Abs trans-
fer across the epithelium of the intestinal surface to the new-
born circulatory system [21]. 
Taking into account the above data, we supposed that it is 
in principle possible that abzymes are present in breast milk 
[22-25]. First the ability of slgA purified from the milk of 
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healthy human mothers to phosphorylate milk proteins was 
shown to be a property of the Abs [24,25]. Recently we have 
shown that DNA- and RNA-hydrolyzing IgG is also present 
in human milk [22,23,26]. In the present article we demon-
strate by different methods that active centers, catalyzing 
DNA hydrolysis, are located on light chains of the IgG anti-
bodies. 
2. Materials and methods 
In this work we used DEAE-cellulose DE-52 (Whatman), Toyo-
pearl HW-55 fine (Toyo Soda), pBR322 plasmid DNA and phage λ 
DNA (Sib-Enzyme, Novosibirsk), all other chemicals were from Sig-
ma or Pharmacia. 
The mixture (20 μΐ) for analysis of DNA-hydrolyzing activity of 
IgG containing 150 ng supercoiled pBR322 DNA, 5 mM MgCl2, 
1 mM EDTA, 20 mM MOPS buffer, pH 7.0, and 2-3 μg of Abs 
was incubated for 1-5 h at 37°C. The cleavage products were analyzed 
by electrophoresis in 0.8% agarose gel. Ethidium bromide-stained gels 
were photographed and the films were scanned. 
Several steps of IgG purification from human milk (100 ml, see 
below) were done as in [26] and then using a DNA-cellulose column 
(8 ml), which was equilibrated in 20 mM Tris-HCl, pH 7.5. Abs were 
eluted with a concentration gradient of NaCl in the same buffer. The 
F(ab)2 and F(ab) fragments were obtained and purified as described 
in [26]. 
IgG subunits were dissociated by incubation at 0.7 mg IgG/ml in 50 
mM Tris-HCl, pH 7.6, containing 0.3 M DDT for 2 h at 30°C, 
addition of urea to 8 M, and incubation for a further 30 min. Then 
IgG subunits were separated on a DNA-cellulose column using the 
above buffer supplemented with 0.3 M dithiothreitol (DTT) and 5 M 
urea. 
Affinity labeling of the light chain was carried out in a 20 μΐ reac-
tion mixture containing 5 μg IgG and 100 pmol of 5'-phospho-(4-
dimethylaminopyridine) derivative of 5'-[32P]d(pT)10 (or [32P]d(pT)10) 
in 20 mM MOPS, pH 7.0, 5 mM MgCl2, incubated for 30 min at 20°C 
and analyzed by SDS-PAGE in reducing conditions. 
DNase activity in the 12% SDS-PAGE gel containing 20 μ^ιηΐ 
phage λ DNA was detected as in [27] : SDS was removed by incubat-
ing the gel for 1 h at 37°C with 7 M urea, the gel was washed 5 times 
with H20, and then to allow protein renaturation it was incubated for 
16 h at 37°C; 20 mM Tris-HCl buffer, pH 7.5, containing 5.0 mM 
MgCb. and 1.0 mM EDTA. For revealing DNA hydrolysis the gel 
was stained with ethidium bromide according to [27]. Then, the posi-
tion of the IgG subunits on the gel was revealed by Coomassie stain-
ing. 
3. Results and discussion 
The pool of human milk Abs consists of 2-3, 1-2 and 93-
96% of IgG, IgM and slgA antibodies, respectively [28]. To 
search for abzymes in the milk of healthy mothers, the IgG 
fraction was purified by chromatography on protein A Se-
pharose in conditions to remove non-specifically bound pro-
teins, followed by DEAE-cellulose and by gel filtration on 
Toyopearl HW 55 to remove slgA [26]. The purity of the 
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Fig. 1. DNase activities of IgG and its fragments: cleavage of 
supercoiled (sc) and relaxed (r) pBR322 DNA by IgG after different 
purification steps (see text): PS, protein A Sepharose; DNA, DNA-
cellulose; GF, gel filtration; pH, abzymes incubated at pH 2.4 and 
then gel-filtered in the same buffer; Fl and F2, Fab and F(ab)2 
fragments of IgG, respectively; L, purified light chain (Fig. 2b); Ki, 
pBR322 DNA before incubation; K2, DNA incubated alone (all 
mixtures were incubated for 4 h). 
150 kDa IgG was confirmed by SDS-PAGE, which showed a 
single band in non-reducing conditions and two bands corre-
sponding to the heavy and light chains after reduction. The 
IgG was found to possess DNase activity at every step of 
purification (Fig. 1) and after the final step of gel filtration 
at pH 2.4 (single peak in conditions of non-covalent protein 
complex dissociation) it contained about 80% of the DNase 
activity loaded on the column [26]. DNase activity was also 
present in homogeneous F(ab)2 and Fab fragments of the 
milk IgG (Fig. 1). 
The properties of the DNase of the milk IgG distinguished 
it from other known DNases. Its pH optimum was 7.0-7.2, a 
value markedly higher than that (5.2 [28]) of human blood 
DNase II, and whereas DNase I is metal-dependent [28] the 
DNAse activity of the milk IgG was only slightly activated by 
Mg2+ or Mn2+ and cleavage of oligodeoxyribonucleotides was 
strongly stimulated by EDTA or after passage through Chelex 
[26]. These data taken together showed that the DNase activ-
ity of milk IgG is an intrinsic property of the IgG, and is not 
due to copurifying DNases [25,26,28]. 
In order to analyze affinity of purified (as described above) 
abzymes to DNA, IgG was chromatographed on DNA-cellu-
lose. Fig. 2 demonstrates that the IgG possesses a heteroge-
neous affinity for DNA: 40-70% of the IgG from 30 different 
INaCll, M 
Fig. 2. Chromatography of the abzymes and their subfragments on DNA-cellulose, a: IgG after purification by gel filtration, b: DNA-purified 
IgG after dissociation into subunits. Inset: SDS-PAGE of peak fractions from (b) in the reducing 12% gel: lanes 1-3 correspond to peaks 1-3, 
(b); 4, molecular mass markers. 
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donors bound to the column, the relative amounts in peaks 1 
and 2 varying between donors. The relative activity of ab-
zymes in hydrolysis of DNA after DNA-cellulose was com-
parable to that at the previous steps of IgG purification (Figs. 
1 and 2). 
The DNase activity resided in the light chain of the IgG, as 
shown by purification on DNA-cellulose after dissociation of 
IgG with urea and DTT (Fig. 2, curve b, peak 2). The light 
chain showed the correct mobility on SDS-PAGE (Fig. 2; 
inset) and reacted with anti-light chain Abs (not shown). 
The relative specific activity of preparations of separated light 
chain was usually lower than that for initial IgG (Fig. 1, line 
L and Fig. 2, peak 2). 
Two further methods provided direct evidence that the light 
chain possessed DNase activity. First, after separation of the 
subunits by SDS-PAGE in a gel containing DNA, an in-gel 
assay showed DNase activity in the light chain (Fig. 3). 
Second, the light chain became specifically labeled after 
incubation of IgG with the phosphorylating affinity reagent 
5'-phospho-(4-dimethylaminopyridine) derivative of 5'-
[32P]d(pT)10 (Fig. 4). 
It should be mentioned that 90-95% of purified IgG (and its 
DNase activity) was adsorbed by Sepharose with immobilized 
monoclonal Abs against χ- and only 5-10%o against λ-light 
chain of human IgG. The data speak in favor of the fact 
that the milk DNA-hydrolyzing abzymes contain χ-type IgG 
light chains. 
These observations demonstrate that DNA-hydrolyzing ab-
zymes are intrinsic components of IgG derived from healthy 
human mother's milk. 
It should be mentioned that specific DNase activities of the 
IgG were 0.5-20% (means of 35 milk samples; only in indi-
vidual milk samples they were higher) of that of DNase I, and 
varied very much for different donors. 
We have not found any detectable level of DNase activity 
in IgG from the blood of normal humans (men and women). 
IgG from mother's sera possessed DNase activity, which was 
lower, comparable or higher than that for IgG from mother's 
milk depending on the donor (detailed data will be published 
separately). 
Fig. 3. DNase activity of the light chain after separation by SDS-
PAGE in a gel containing DNA; 1, DNase activity revealed as a 
sharp dark band on a fluorescent background after ethidium bro-
mide staining; 2, gel stained with Coomassie; 3, molecular mass 
markers. 
Fig. 4. Affinity labeling of the light chain at incubation of IgG with 
32P-labeled 5'-phospho-(4-dimethylaminopyridine) derivative of 
d(pT)io: 1 and 2, autoradiographs of a SDS-PAGE gel of IgG be-
fore and after incubation with [32P]d(pT)io ; 3 and 4, the same be-
fore and after incubation of IgG with the probe; 5, gel stained with 
silver. 
So far an important question remains unanswered: what is 
the biological role of the abzymes in the blood of patients 
with various autoimmune diseases? Is it a function or a dys-
function of autoimmune Abs? 
It is known that an increased amount of DNases and 
RNases in human blood or nuclease therapy of patients leads 
to protection against different viral and bacterial diseases [29-
31]. Recently, an inverse correlation between mammary tumor 
incidence and amount of RNase activity in the milk plasma 
was revealed [32]. One can suppose that the milk DNA- and 
RNA-hydrolyzing abzymes are capable not only of neutraliz-
ing viral and bacterial nucleic acids due to complex formation 
with them, but also of hydrolyzing them. The DNA-hydro-
lyzing activity of Abs raises the possibility that these abzymes 
may provide protective functions for the newborn through the 
hydrolysis of viral and bacterial nucleic acids. Thus, the 
DNA-hydrolyzing activity of milk abzymes probably may 
have a positive function. 
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